SOAT1 and cancer: As reviewed in detail elsewhere, various in vivo and in vitro data demonstrated hyperactivation of JAK/STAT signaling, especially STAT3, in cancer cells contributing to cancer progression and radio- and chemoresistance [24,54,55,56].